Yahoo India Web Search

Search results

  1. 2016. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. EJ Topol, DJ...

  2. ‪Department of Anthropology, National Taiwan University‬ - ‪‪Cited by 1,598‬‬

  3. Profile. Education: Ph. D. , Harvard University, Department of Anthropology (2001.11) Positions Held: Assistant Professor, National Taiwan University, Anthropology Department, 2015-present. Adjunct Assistant Professor of Archaeology, Archaeology Department, Boston University, 2006-2017.

  4. David COHEN, Professor (Associate) | Cited by 1,180 | of National Taiwan University, Taipei (NTU) | Read 22 publications | Contact David COHEN

  5. www.crf.org › clinical-trials-center › about-usStaff Bios - CRF

    David J. Cohen, MD, MSc – Director of Clinical and Outcomes Research Dr. Cohen is Director of Academic Affairs at St. Francis Hospital & Heart Center in Roslyn, New York. A world-renowned expert in health economics and outcomes research, Dr. Cohen has devoted his career to studying interventional cardiology devices and procedures ...

    • David J. Cohen1
    • David J. Cohen2
    • David J. Cohen3
    • David J. Cohen4
    • David J. Cohen5
  6. David J. Cohen, MD, MSc, ( @djc795) is Director of Clinical and Outcomes Research at the Cardiovascular Research Foundation (New York, NY) and Director of Academic Affairs at St. Francis Hospital (Roslyn, NY).

  7. Jan 6, 2021 · A world-renowned expert in health economics and outcomes research, Dr. Cohen has devoted his career to studying interventional cardiology devices and procedures, particularly drug-eluting stents and transcatheter aortic valve implantation.